US FDA’s Accelerated Approval Council: Bigger Role, More Transparency Coming?

2024/2025 Pink Sheet Perspectives
The expedited withdrawal procedures were pressure-tested by Pepaxto in 2024. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pink Sheet Perspectives

More from Pathways & Standards